NYSE to Commence Delisting Proceedings Against Diebold Nixdorf, Incorporated (DBD)

The New York Stock Exchange LLC (“NYSE” or “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the common shares of Diebold Nixdorf, Incorporated (the “Company”) — ticker symbol DBD — from the NYSE. Trading in the Company’s common shares will be suspended immediately.

NYSE Regulation reached its decision that the Company is no longer suitable for listing pursuant to Listed Company Manual Section 802.01D after the Company’s May 30, 2023 and June 1, 2023 disclosures that the Company has filed voluntary petitions for relief under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the Southern District of Texas. In reaching its delisting determination, NYSE Regulation noted that the Company’s outstanding common shares would be cancelled pursuant to the restructuring transactions, and holders thereof would not receive any recovery.

The Company has a right to a review of this determination by a Committee of the Board of Directors of the Exchange. The NYSE will apply to the Securities and Exchange Commission to delist the Company’s common shares upon completion of all applicable procedures, including any appeal by the Company of the NYSE Regulation staff’s decision.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230602005336/en/